Biotech
Companies in the biotech (biotechnology) space manufacture drugs, therapies, vaccines, and medical diagnostic tests for the treatment of health disorders and illnesses. Demand for biotechnology in the fields of medicine, agriculture, food, and science is driven by insurers' willingness to pay for new medical treatments, the global need to produce more food for a rapidly expanding population, and scientists' desire to find solutions for complex scientific and medical issues. The industry is considered one of the riskiest for investors as drug development success is a difficult and costly process.
Share This Page
Industry Rating
Loading, please wait...
Rk | Symbol | Name | Last | Day
Chg
| Mkt
Cap
| POWR
|
|---|---|---|---|---|---|---|
| 1 | OTSKY | Otsuka Holdings Co Ltd | 24.88 | -0.41 (-1.62%) | N/A | A |
| 2 | NPPNY | Nippon Shinyaku Co., Ltd. | 6.18 | 0.12 (1.90%) | N/A | A |
| 3 | HRMY | Harmony Biosciences Holdings Inc. | 32.90 | -0.07 (-0.21%) | 1.89B | A |
| 4 | INCY | Incyte Corp. | 71.22 | 3.47 (5.12%) | 13.79B | A |
| 5 | BMRN | BioMarin Pharmaceutical Inc | 56.24 | 0.02 (0.04%) | 10.79B | A |
| 6 | GMAB | Genmab A/S ADR | 22.86 | 0.04 (0.18%) | 14.66B | A |
| 7 | GILD | Gilead Sciences Inc. | 110.83 | 0.85 (0.77%) | 137.86B | A |
| 8 | AMGN | Amgen Inc. | 295.56 | 0.34 (0.12%) | 158.92B | A |
| 9 | SGIOY | Shionogi & Co., Ltd. | 8.64 | 0.09 (1.02%) | 14.69B | B |
| 10 | PBYI | Puma Biotechnology Inc | 3.45 | 0.10 (2.99%) | 171.23M | B |
| 11 | BCRX | BioCryst Pharmaceuticals, Inc. | 10.29 | -0.08 (-0.77%) | 2.15B | B |
| 12 | EXEL | Exelixis, Inc. | 41.75 | 0.16 (0.38%) | 11.39B | B |
| 13 | CSBR | Champions Oncology, Inc. | 7.61 | -0.05 (-0.65%) | 105.22M | B |
| 14 | SBHMY | Sino Biopharmaceutical Limited | 9.48 | 0.69 (7.85%) | N/A | B |
| 15 | ILMN | Illumina Inc. | 90.25 | 3.32 (3.82%) | 14.29B | B |
| 16 | MNKD | MannKind Corporation | 3.81 | 0.10 (2.70%) | 1.16B | B |
| 17 | UTHR | United Therapeutics Corporation | 288.56 | 5.21 (1.84%) | 13.02B | B |
| 18 | PTCT | PTC Therapeutics, Inc. | 51.87 | 0.61 (1.19%) | 4.11B | B |
| 19 | UCBJY | UCB SA | 93.45 | -0.51 (-0.54%) | 35.33B | B |
| 20 | XLO | Xilio Therapeutics, Inc. | 0.69 | 0.02 (3.56%) | 35.52M | B |
| 21 | LJPC | La Jolla Pharmaceutical Company | 6.22 | 0.00 (0.00%) | 155.11M | NR |
| 22 | ALKS | Alkermes plc - Ordinary Shares | 29.42 | -0.41 (-1.37%) | 4.85B | B |
| 23 | MKKGY | Merck KGaA | 26.52 | 0.14 (0.53%) | 17.14B | B |
| 24 | VRTX | Vertex Pharmaceuticals Inc. | 450.91 | -4.54 (-1.00%) | 115.79B | B |
| 25 | ADAP | Adaptimmune Therapeutics plc | 0.25 | 0.01 (4.91%) | 67.38M | B |
| 26 | HALO | Halozyme Therapeutics, Inc. | 53.92 | -0.06 (-0.11%) | 6.64B | B |
| 27 | BIIB | Biogen Inc. | 131.04 | 0.39 (0.30%) | 19.20B | B |
| 28 | IPSC | Century Therapeutics, Inc. | 0.58 | 0.01 (1.32%) | 50.23M | B |
| 29 | IMCR | Immunocore Holdings plc | 32.91 | -1.77 (-5.10%) | 1.65B | B |
| 30 | ACOR | Acorda Therapeutics, Inc. | 0.66 | -0.22 (-24.86%) | 820.96K | NR |
| 31 | BDTX | Black Diamond Therapeutics Inc. | 2.39 | 0.08 (3.46%) | 135.90M | B |
| 32 | INVA | Innoviva, Inc. | 21.80 | 0.11 (0.51%) | 1.37B | B |
| 33 | PLX | Protalix BioTherapeutics, Inc. (DE) | 1.43 | -0.06 (-4.03%) | 113.84M | B |
| 34 | GOSS | Gossamer Bio, Inc. | 1.28 | 0.04 (3.23%) | 290.95M | B |
| 35 | EQ | Equillium, Inc. | 0.34 | -0.01 (-1.99%) | 12.15M | B |
| 36 | TAIPY | Taisho Pharmaceutical Holdings Company Ltd. | 14.00 | 2.00 (16.67%) | N/A | B |
| 37 | KROS | Keros Therapeutics Inc. | 13.66 | 0.10 (0.74%) | 554.80M | B |
| 38 | ARWR | Arrowhead Pharmaceuticals, Inc. | 15.70 | -0.04 (-0.25%) | 2.17B | B |
| 39 | GNFT | GENFIT S.A. | 4.15 | 0.05 (1.22%) | 207.48M | NR |
| 40 | ZYME | Zymeworks Inc. Common Shares | 12.65 | -0.02 (-0.16%) | 880.15M | B |
| 41 | AVEO | AVEO Pharmaceuticals, Inc. | 15.00 | 0.00 (0.00%) | 521.45M | NR |
| 42 | GLUE | Monte Rosa Therapeutics, Inc. | 4.82 | -0.09 (-1.83%) | 296.48M | B |
| 43 | TECH | Bio-Techne Corp | 51.63 | 1.11 (2.20%) | 8.09B | B |
| 44 | VXRT | Vaxart Inc. | 0.66 | -0.04 (-5.97%) | 150.71M | B |
| 45 | DCPH | Deciphera Pharmaceuticals, Inc. | 25.59 | 0.02 (0.08%) | 2.21B | C |
| 46 | STOK | Stoke Therapeutics Inc. | 11.70 | 0.17 (1.47%) | 638.78M | C |
| 47 | JNCE | Jounce Therapeutics, Inc. | 1.88 | -0.05 (-2.59%) | 98.95M | NR |
| 48 | TCON | TRACON Pharmaceuticals, Inc. | 0.03 | -0.01 (-25.98%) | 109.74K | C |
| 49 | BNTX | BioNTech SE ADR | 106.33 | -0.24 (-0.23%) | 25.56B | C |
| 50 | VCYT | Veracyte, Inc. | 26.64 | 0.20 (0.76%) | 2.09B | C |
| 51 | ICPT | Intercept Pharmaceuticals, Inc. | 19.00 | 0.04 (0.21%) | 793.88M | NR |
| 52 | KRYS | Krystal Biotech, Inc. | 133.05 | -4.02 (-2.93%) | 3.85B | C |
| 53 | FULC | Fulcrum Therapeutics, Inc. | 6.80 | -0.05 (-0.73%) | 367.06M | C |
| 54 | ALNY | Alnylam Pharmaceuticals Inc. | 308.78 | 0.79 (0.26%) | 40.26B | C |
| 55 | RPRX | Royalty Pharma PLC | 35.10 | 0.26 (0.75%) | 19.73B | C |
| 56 | BDSI | BioDelivery Sciences International, Inc. | 5.59 | -0.01 (-0.18%) | 577.05M | NR |
| 57 | AYTU | Aytu BioScience, Inc. | 1.98 | 0.03 (1.54%) | 12.22M | NR |
| 58 | TBPH | Theravance Biopharma, Inc. - Ordinary Shares | 10.75 | 0.06 (0.56%) | 537.51M | C |
| 59 | SIGA | SIGA Technologies Inc. | 6.50 | 0.14 (2.20%) | 464.37M | C |
| 60 | TRDA | Entrada Therapeutics, Inc. | 7.41 | -0.18 (-2.37%) | 281.23M | C |
| 61 | PRTK | Paratek Pharmaceuticals, Inc. | 2.23 | 0.04 (1.83%) | 127.83M | NR |
| 62 | EBS | Emergent Biosolutions, Inc. | 6.24 | -0.01 (-0.16%) | 338.69M | C |
| 63 | AGEN | Agenus Inc. | 5.14 | 0.44 (9.36%) | 140.92M | C |
| 64 | FGEN | FibroGen, Inc | 0.27 | 0.00 (0.83%) | 26.89M | C |
| 65 | ATRA | Atara Biotherapeutics, Inc. | 8.58 | -0.24 (-2.72%) | 51.15M | C |
| 66 | CRMD | CorMedix Inc. | 14.34 | -0.22 (-1.51%) | 972.61M | C |
| 67 | ORGO | Organogenesis Holdings Inc. | 3.24 | 0.17 (5.54%) | 411.01M | C |
| 68 | REGN | Regeneron Pharmaceuticals Inc. | 522.68 | -6.56 (-1.24%) | 56.43B | C |
| 69 | MOLN | MOLECULAR PARTNERS AG | 3.84 | 0.00 (0.00%) | 155.04M | NR |
| 70 | SOLCF | SOL Global Investments Corp. | 0.05 | 0.00 (0.76%) | N/A | NR |
| 71 | XOMA | XOMA Corporation | 24.27 | 0.42 (1.76%) | 290.44M | C |
| 72 | THTX | Theratechnologies, Inc. | 2.42 | -0.06 (-2.42%) | 111.27M | C |
| 73 | RGNX | REGENXBIO Inc. | 9.16 | -0.11 (-1.19%) | 459.47M | C |
| 74 | BLPH | Bellerophon Therapeutics, Inc. | 0.01 | -0.00 (-25.47%) | 146.80K | NR |
| 75 | FOLD | Amicus Therapeutics, Inc. | 6.05 | 0.02 (0.33%) | 1.86B | C |
| 76 | KURA | Kura Oncology, Inc. | 6.49 | 0.05 (0.78%) | 561.87M | C |
| 77 | JAZZ | Jazz Pharmaceuticals plc - Ordinary Shares | 109.64 | 1.14 (1.05%) | 6.63B | C |
| 78 | CORT | Corcept Therapeutics Incorporated | 70.90 | 0.84 (1.20%) | 7.52B | C |
| 79 | ALLK | Allakos Inc. | 0.33 | -0.00 (-0.06%) | 29.74M | C |
| 80 | VNDA | Vanda Pharmaceuticals Inc. | 4.58 | 0.07 (1.55%) | 269.92M | C |
| 81 | HRTX | Heron Therapeutics, Inc. | 2.03 | 0.10 (5.18%) | 309.70M | C |
| 82 | ANIK | Anika Therapeutics Inc. | 11.11 | 0.18 (1.65%) | 159.33M | C |
| 83 | SRZN | Surrozen, Inc | 9.54 | 0.06 (0.63%) | 81.69M | C |
| 84 | VACC | Vaccitech plc | 5.00 | 0.51 (11.36%) | 192.74M | NR |
| 85 | MGNX | MacroGenics, Inc. | 1.50 | -0.02 (-1.32%) | 94.64M | C |
| 86 | INFI | Infinity Pharmaceuticals, Inc. | 0.01 | -0.01 (-50.00%) | 719.28K | NR |
| 87 | CERS | Cerus Corporation | 1.41 | 0.09 (6.82%) | 269.54M | C |
| 88 | VALN | Valneva SE | 6.07 | 0.07 (1.17%) | 516.52M | C |
| 89 | SELB | Selecta Biosciences, Inc. | 0.88 | -0.08 (-8.00%) | 136.77M | NR |
| 90 | PMCB | PharmaCyte Biotech Inc. | 1.01 | 0.00 (0.00%) | 6.93M | NR |
| 91 | KRON | Kronos Bio Inc. | 0.89 | -0.01 (-0.57%) | 54.18M | C |
| 92 | IFRX | InflaRx N.V. | 0.78 | -0.00 (-0.51%) | 52.36M | C |
| 93 | CVAC | CureVac N.V | 5.52 | -0.05 (-0.90%) | 1.24B | C |
| 94 | IMGN | ImmunoGen, Inc. | 31.23 | 0.00 (0.00%) | 8.32B | NR |
| 95 | GRPH | Graphite Bio, Inc. | 3.18 | -0.09 (-2.75%) | 185.19M | NR |
| 96 | MIRO | Miromatrix Medical Inc. | 3.39 | 0.02 (0.59%) | 92.95M | NR |
| 97 | FHTX | Foghorn Therapeutics, Inc. | 4.39 | 0.07 (1.62%) | 244.70M | C |
| 98 | BGNE | BeiGene Ltd. ADR | 184.71 | 0.90 (0.49%) | 18.03B | C |
| 99 | NXTC | NextCure, Inc. | 0.50 | -0.18 (-26.27%) | 14.08M | C |
| 100 | NVAX | Novavax, Inc. | 7.03 | 0.09 (1.30%) | 1.14B | C |
| 101 | SEEL | Seelos Therapeutics, Inc. | 0.39 | -0.15 (-27.79%) | 145.08K | C |
| 102 | LVTX | LAVA Therapeutics BV | 1.29 | -0.02 (-1.53%) | 33.93M | C |
| 103 | IMRA | Imara Inc. | 50.00 | 0.90 (1.83%) | 5.00M | NR |
| 104 | GTHX | G1 Therapeutics, Inc. | 7.15 | 0.00 (0.00%) | 373.81M | C |
| 105 | ANGN | Angion Biomedica Corp | 1.00 | 0.02 (2.04%) | 30.11M | NR |
| 106 | BOLT | Bolt Biotherapeutics, Inc. | 5.77 | -0.33 (-5.41%) | 11.06M | C |
| 107 | CALA | Calithera Biosciences, Inc. | 0.00 | -0.00 (-95.00%) | 0.49K | NR |
| 108 | ALVR | AlloVir Inc. | 9.81 | 0.15 (1.55%) | 49.47M | C |
| 109 | KZR | Kezar Life Sciences, Inc. | 4.34 | -0.25 (-5.45%) | 31.71M | C |
| 110 | PASG | Passage Bio Inc. | 0.40 | 0.01 (3.02%) | 25.03M | C |
| 111 | CYT | Cyteir Therapeutics, Inc. | 3.02 | -0.07 (-2.27%) | 108.71M | NR |
| 112 | CDAK | Codiak BioSciences Inc. | 0.06 | -0.07 (-55.98%) | 2.10M | NR |
| 113 | RPHM | Reneo Pharmaceuticals, Inc. | 1.82 | 0.09 (5.20%) | 60.83M | C |
| 114 | AKBA | Akebia Therapeutics, Inc. | 3.58 | 0.02 (0.56%) | 940.24M | C |
| 115 | SGMO | Sangamo Therapeutics, Inc. | 0.50 | 0.01 (1.83%) | 116.58M | C |
| 116 | RARE | Ultragenyx Pharmaceutical Inc. | 37.11 | -0.38 (-1.01%) | 3.51B | C |
| 117 | SEER | Seer Inc. Cl A | 2.02 | -0.05 (-2.42%) | 118.92M | C |
| 118 | BNTC | Benitec Biopharma Inc. | 15.75 | -0.73 (-4.43%) | 413.44M | C |
| 119 | ANAB | AnaptysBio, Inc. | 23.90 | 0.58 (2.49%) | 702.18M | C |
| 120 | SESN | Sesen Bio, Inc. | 0.63 | 0.04 (7.29%) | 127.96M | NR |
| 121 | ERAS | Erasca, Inc. | 1.41 | -0.08 (-5.07%) | 398.02M | C |
| 122 | HARP | Harpoon Therapeutics, Inc. | 23.01 | 0.02 (0.09%) | 389.61M | NR |
| 123 | ASLN | ASLAN Pharmaceuticals Limited | 0.60 | -0.10 (-14.27%) | 1.23M | C |
| 124 | ASND | Ascendis Pharma A/S | 177.71 | 6.91 (4.05%) | 10.86B | C |
| 125 | CGEN | Compugen Ltd. - Ordinary Shares | 1.65 | 0.01 (0.61%) | 147.24M | C |
| 126 | NBSE | NeuBase Therapeutics, Inc. | 0.38 | -0.01 (-3.20%) | 1.42M | NR |
| 127 | ITCI | Intra-Cellular Therapies Inc. | 131.87 | -0.05 (-0.04%) | 14.05B | C |
| 128 | CSLLY | CSL Ltd. ADR | 78.47 | 0.93 (1.20%) | 75.99B | C |
| 129 | ANIP | ANI Pharmaceuticals, Inc. | 64.29 | 1.73 (2.77%) | 1.39B | C |
| 130 | ADCT | ADC Therapeutics S.A. | 3.38 | -0.20 (-5.59%) | 335.22M | C |
| 131 | ATAI | ATAI Life Sciences N.V. | 2.24 | 0.13 (6.16%) | 448.76M | C |
| 132 | MRKR | Marker Therapeutics, Inc. | 1.52 | -0.08 (-5.00%) | 17.20M | C |
| 133 | ONCT | Oncternal Therapeutics, Inc. | 0.53 | -0.17 (-24.11%) | 1.56M | C |
| 134 | IPHA | INNATE PHARMA SA | 1.87 | -0.03 (-1.32%) | 172.37M | NR |
| 135 | ADPT | Adaptive Biotechnologies Corporation | 10.29 | -0.03 (-0.29%) | 1.56B | C |
| 136 | CINC | CinCor Pharma, Inc., | 29.06 | -0.14 (-0.48%) | 1.27B | NR |
| 137 | RGEN | Repligen Corporation | 126.09 | -1.43 (-1.12%) | 7.08B | C |
| 138 | SQZ | SQZ Biotechnologies Co. | 0.44 | 0.17 (61.11%) | 12.83M | NR |
| 139 | EPZM | Epizyme, Inc. | 1.47 | -0.02 (-1.34%) | 247.44M | NR |
| 140 | AVIR | Atea Pharmaceuticals Inc. | 3.19 | 0.03 (0.95%) | 273.00M | C |
| 141 | DVAX | Dynavax Technologies Corporation | 10.17 | -0.10 (-0.97%) | 1.22B | C |
| 142 | OBSV | ObsEva SA | 0.10 | -0.02 (-15.52%) | 7.94M | NR |
| 143 | BDSX | Biodesix Inc. | 0.29 | 0.00 (0.38%) | 42.18M | C |
| 144 | APOP | Cellect Biotechnology Ltd. | 13.17 | 0.05 (0.38%) | 12.87M | NR |
| 145 | TVTX | Travere Therapeutics, Inc. | 14.68 | 0.18 (1.24%) | 1.30B | C |
| 146 | PCSA | Processa Pharmaceuticals, Inc. | 0.23 | -0.03 (-12.92%) | 2.68M | C |
| 147 | CTIC | CTI BioPharma Corp. | 9.09 | 0.00 (0.00%) | 1.20B | NR |
| 148 | QLI | Qilian International Holding Group Limited | 5.41 | -0.35 (-6.08%) | 38.68M | NR |
| 149 | KMPH | KemPharm, Inc. | 5.81 | -0.02 (-0.34%) | 200.47M | NR |
| 150 | CASI | CASI Pharmaceuticals, Inc. | 1.33 | -0.51 (-27.72%) | 16.36M | C |
| 151 | SNSE | Sensei Biotherapeutics, Inc. | 0.33 | 0.03 (8.67%) | 8.22M | C |
| 152 | ATHE | Alterity Therapeutics Limited | 4.41 | 0.01 (0.34%) | 39.10M | C |
| 153 | HLVX | HilleVax, Inc., | 1.86 | 0.01 (0.54%) | 93.26M | C |
| 154 | CNTB | Connect Biopharma Holdings Limited | 0.98 | 0.03 (3.15%) | 54.44M | C |
| 155 | KNTE | Kinnate Biopharma | 2.65 | -0.01 (-0.38%) | 125.15M | C |
| 156 | TGTX | TG Therapeutics, Inc. | 35.63 | -0.38 (-1.06%) | 5.66B | C |
| 157 | TSVT | 2seventy bio Inc. | 5.00 | 0.01 (0.20%) | 266.15M | C |
| 158 | PNT | POINT Biopharma Global Inc., | 12.50 | 0.02 (0.16%) | 1.33B | NR |
| 159 | SGEN | Seagen Inc. | 228.74 | -0.16 (-0.07%) | 42.93B | NR |
| 160 | THRX | Theseus Pharmaceuticals, Inc. | 4.06 | 0.00 (0.00%) | 179.57M | NR |
| 161 | OCUP | Ocuphire Pharma Inc. | 1.17 | -0.16 (-12.03%) | 30.33M | C |
| 162 | VRNA | Verona Pharma plc - American Depositary Share | 92.70 | 0.50 (0.54%) | 7.52B | C |
| 163 | STSA | SATSUMA PHARMACEUTICALS, INC. | 1.10 | -0.01 (-0.90%) | 36.47M | NR |
| 164 | MCRB | Seres Therapeutics, Inc. | 7.50 | 0.00 (0.00%) | 65.49M | C |
| 165 | OTIC | Otonomy, Inc. | 0.01 | -0.11 (-92.64%) | 582.48K | NR |
| 166 | NLTX | Neoleukin Therapeutics, Inc. | 3.49 | 0.05 (1.45%) | 32.80M | NR |
| 167 | ZNTL | Zentalis Pharmaceuticals Inc. | 1.51 | 0.17 (12.69%) | 108.65M | C |
| 168 | PMVP | PMV Pharmaceuticals Inc. | 1.07 | -0.01 (-0.93%) | 55.59M | C |
| 169 | RVNC | Revance Therapeutics, Inc. | 3.65 | 0.01 (0.27%) | 381.02M | C |
| 170 | CLVS | Clovis Oncology, Inc. | 0.08 | -0.00 (-5.58%) | 11.77M | NR |
| 171 | CYCN | Cyclerion Therapeutics, Inc. | 3.09 | -0.03 (-0.92%) | 9.92M | C |
| 172 | AVRO | AVROBIO, Inc. | 1.40 | -0.02 (-1.41%) | 62.85M | C |
| 173 | IOBT | IO Biotech, Inc. | 1.32 | -0.03 (-2.22%) | 86.96M | C |
| 174 | TARS | Tarsus Pharmaceuticals Inc. | 41.29 | 0.40 (0.98%) | 1.73B | C |
| 175 | GBT | Global Blood Therapeutics, Inc. | 68.49 | 0.01 (0.01%) | 4.62B | NR |
| 176 | DAWN | Day One Biopharmaceuticals, Inc. | 6.64 | -0.03 (-0.45%) | 673.04M | C |
| 177 | ENLV | Enlivex Therapeutics Ltd. | 1.03 | 0.13 (14.44%) | 24.36M | C |
| 178 | STTK | Shattuck Labs Inc. | 1.00 | -0.01 (-0.99%) | 47.90M | C |
| 179 | VERV | Verve Therapeutics, Inc. | 6.27 | 0.11 (1.79%) | 558.93M | C |
| 180 | CERT | Certara Inc. | 10.76 | -0.25 (-2.27%) | 1.75B | C |
| 181 | LUMO | Lumos Pharma, Inc. | 4.34 | 0.00 (0.00%) | 37.54M | C |
| 182 | GRTX | GALERA THERAPEUTICS, INC. | 0.03 | 0.00 (7.41%) | 2.19M | NR |
| 183 | NBY | NovaBay Pharmaceuticals, Inc. | 0.60 | 0.00 (0.00%) | 3.49M | C |
| 184 | HSTO | Histogen Inc. | 0.22 | 0.00 (0.00%) | 918.05K | NR |
| 185 | CADL | Candel Therapeutics, Inc. | 5.16 | 0.03 (0.58%) | 258.53M | C |
| 186 | BCEL | Atreca, Inc. - | 0.09 | -0.00 (-1.32%) | 3.57M | NR |
| 187 | LIAN | LianBio | 0.32 | -0.03 (-8.28%) | 34.47M | NR |
| 188 | SAGE | Sage Therapeutics, Inc. | 9.07 | 2.37 (35.37%) | 567.97M | C |
| 189 | DRNA | Dicerna Pharmaceuticals, Inc. | 38.22 | 0.22 (0.58%) | 2.99B | NR |
| 190 | ANEB | Anebulo Pharmaceuticals, Inc. | 1.58 | 0.19 (13.67%) | 64.91M | NR |
| 191 | PRTA | Prothena Corporation plc - Ordinary Shares | 5.66 | 0.58 (11.42%) | 304.66M | C |
| 192 | IGMS | IGM BIOSCIENCES, INC. | 1.22 | 0.01 (0.83%) | 72.93M | C |
| 193 | BPMC | Blueprint Medicines Corporation | 128.25 | 0.29 (0.23%) | 8.28B | C |
| 194 | PSTI | Pluristem Therapeutics, Inc. | 1.00 | -0.03 (-2.91%) | 32.35M | NR |
| 195 | ANTX | AN2 Therapeutics, Inc., | 1.08 | 0.01 (0.93%) | 32.59M | C |
| 196 | GERN | Geron Corporation | 1.55 | 0.04 (2.65%) | 987.22M | C |
| 197 | CCXI | ChemoCentryx, Inc. | 51.99 | 0.03 (0.06%) | 3.71B | NR |
| 198 | SPPI | Spectrum Pharmaceuticals, Inc. | 1.03 | 0.00 (0.00%) | 211.40M | NR |
| 199 | AMRN | Amarin Corp. PLC ADR | 13.88 | 0.63 (4.75%) | 287.41M | C |
| 200 | CRIS | Curis, Inc. | 2.47 | 0.02 (0.82%) | 25.84M | C |
| 201 | BBI | Brickell Biotech, Inc. | 2.35 | 0.05 (2.17%) | 6.75M | NR |
| 202 | GHRS | GH Research PLC | 12.72 | -0.04 (-0.31%) | 661.80M | C |
| 203 | FRLN | Freeline Therapeutics Holdings PLC ADR | 6.48 | 0.00 (0.00%) | 28.13M | NR |
| 204 | CLSN | Celsion Corporation | 1.96 | 0.00 (0.00%) | 13.91M | NR |
| 205 | FATE | Fate Therapeutics, Inc. | 1.24 | -0.04 (-2.75%) | 142.11M | C |
| 206 | ARAV | Aravive, Inc. | 0.04 | -0.01 (-13.39%) | 2.95M | NR |
| 207 | INAB | IN8bio, Inc. | 2.21 | -0.05 (-2.21%) | 6.68M | C |
| 208 | ESPR | Esperion Therapeutics, Inc. | 1.17 | 0.00 (0.00%) | 231.89M | C |
| 209 | GMTX | Gemini Therapeutics, Inc. | 1.35 | 0.00 (0.00%) | 58.49M | NR |
| 210 | SRPT | Sarepta Therapeutics, Inc. | 20.94 | -15.24 (-42.12%) | 2.06B | C |
| 211 | ARQT | Arcutis Biotherapeutics Inc. | 13.40 | -0.03 (-0.22%) | 1.60B | C |
| 212 | VIGL | Vigil Neuroscience, Inc., | 7.88 | 0.02 (0.25%) | 367.78M | C |
| 213 | VECT | VectivBio Holding AG | 16.85 | 0.00 (0.00%) | 573.24M | NR |
| 214 | SGTX | Sigilon Therapeutics Inc. | 22.47 | -0.59 (-2.56%) | 56.49M | NR |
| 215 | CLNN | Clene Inc. | 4.42 | 0.32 (7.80%) | 39.70M | C |
| 216 | SCPS | Scopus Biopharma Inc. | 0.01 | 0.01 (3,233.33%) | 420.84K | NR |
| 217 | PIRS | Pieris Pharmaceuticals, Inc. | 13.60 | -2.53 (-15.69%) | 17.95M | C |
| 218 | GNLX | Genelux Corp. | 3.23 | 0.17 (5.56%) | 121.88M | C |
| 219 | MITO | Stealth BioTherapeutics Corp. - ADS | 0.32 | -0.00 (-1.36%) | 23.54M | NR |
| 220 | CYTR | CytRx Corporation | 0.09 | 0.00 (0.00%) | 4.14M | NR |
| 221 | TLGT | Teligent, Inc. | 0.17 | -0.03 (-13.85%) | 16.10M | NR |
| 222 | FNCH | Finch Therapeutics Group, Inc., | 13.60 | -0.15 (-1.09%) | 21.84M | NR |
| 223 | TALS | Talaris Therapeutics, Inc. | 2.72 | -0.02 (-0.73%) | 116.32M | NR |
| 224 | SPRB | Spruce Biosciences Inc. | 0.07 | -0.00 (-0.80%) | 3.13M | C |
| 225 | BNGO | Bionano Genomics, Inc. | 3.54 | -0.11 (-3.01%) | 11.91M | C |
| 226 | DMAC | DiaMedica Therapeutics Inc. | 3.51 | -0.14 (-3.84%) | 150.52M | C |
| 227 | REPH | Recro Pharma, Inc. | 2.09 | -0.01 (-0.48%) | 117.93M | NR |
| 228 | TWST | Twist Bioscience Corporation | 35.04 | 1.52 (4.53%) | 2.10B | C |
| 229 | VOR | Vor Biopharma Inc. | 0.22 | 0.04 (21.75%) | 27.70M | C |
| 230 | SNSS | Sunesis Pharmaceuticals, Inc. | 5.32 | 1.04 (24.30%) | 96.25M | NR |
| 231 | MACK | Merrimack Pharmaceuticals, Inc. | 15.13 | 0.00 (0.00%) | 223.74M | C |
| 232 | LEGN | Legend Biotech Corp. ADR | 35.84 | -0.99 (-2.69%) | 6.59B | C |
| 233 | SABS | SAB Biotherapeutics, Inc., | 1.70 | -0.01 (-0.58%) | 15.79M | C |
| 234 | VIR | VIR BIOTECHNOLOGY, INC. | 5.24 | 0.02 (0.38%) | 724.37M | C |
| 235 | TELA | TELA BIO, INC. | 1.61 | -0.09 (-5.29%) | 63.68M | C |
| 236 | MNOV | MediciNova, Inc. | 1.33 | 0.00 (0.00%) | 65.23M | NR |
| 237 | EDIT | Editas Medicine, Inc. | 2.16 | 0.19 (9.64%) | 180.82M | C |
| 238 | FBIO | Fortress Biotech, Inc. | 1.84 | -0.01 (-0.54%) | 54.41M | C |
| 239 | INBX | Inhibrx Inc. | 14.62 | 0.05 (0.34%) | 211.64M | C |
| 240 | NRXP | NRx Pharmaceuticals, Inc. | 3.48 | 0.04 (1.16%) | 60.17M | C |
| 241 | RUBY | Rubius Therapeutics, Inc. | 0.06 | 0.00 (2.70%) | 5.16M | NR |
| 242 | HGEN | Humanigen, Inc. | 0.00 | -0.00 (-84.62%) | 23.82K | NR |
| 243 | IKNA | Ikena Oncology, Inc. | 1.41 | 0.06 (4.44%) | 68.04M | C |
| 244 | HCWB | HCW Biologics Inc. | 5.35 | -0.10 (-1.83%) | 7.70M | C |
| 245 | AWH | Aspira Women's Health Inc. | 0.08 | -0.01 (-12.49%) | 2.44M | C |
| 246 | ELYM | Eliem Therapeutics, Inc. | 5.11 | -0.05 (-0.97%) | 152.03M | C |
| 247 | GLS | Gelesis Holdings Inc., | 0.16 | 0.00 (0.38%) | 11.63M | NR |
| 248 | ATHX | Athersys, Inc. | 0.01 | -0.01 (-33.50%) | 833.21K | NR |
| 249 | PTE | PolarityTE, Inc. | 0.24 | -0.00 (-0.82%) | 1.78M | NR |
| 250 | BTX | Brooklyn ImmunoTherapeutics Inc. | 7.14 | 0.05 (0.71%) | 420.02M | NR |
| 251 | LTRN | Lantern Pharma Inc. | 3.20 | 0.15 (4.92%) | 34.51M | C |
| 252 | DFFN | Diffusion Pharmaceuticals Inc. | 4.40 | 0.46 (11.68%) | 8.98M | NR |
| 253 | NK | NantKwest, Inc. | 32.49 | 4.21 (14.89%) | 3.55B | NR |
| 254 | MDNA | Medicenna Therapeutics Corp. | 0.16 | -0.02 (-13.16%) | 10.93M | NR |
| 255 | LYEL | Lyell Immunopharma, Inc. | 10.17 | 0.43 (4.41%) | 150.60M | C |
| 256 | UPC | Universe Pharmaceuticals INC | 3.95 | -0.03 (-0.75%) | 169.85K | C |
| 257 | NKTR | Nektar Therapeutics | 9.25 | 0.66 (7.68%) | 114.82M | C |
| 258 | ABUS | Arbutus Biopharma Corporation | 3.58 | 0.05 (1.42%) | 685.67M | C |
| 259 | ATHA | Athira Pharma Inc. | 0.32 | 0.02 (5.39%) | 12.51M | C |
| 260 | SRNE | Sorrento Therapeutics Inc. | 0.00 | 0.00 (19.05%) | 1.38M | NR |
| 261 | MRSN | Mersana Therapeutics, Inc. | 0.38 | 0.01 (3.46%) | 47.35M | C |
| 262 | CCCC | C4 Therapeutics Inc. | 1.63 | -0.05 (-2.98%) | 115.74M | D |
| 263 | ENSC | Ensysce Biosciences, Inc | 2.15 | 0.08 (3.86%) | 5.10M | D |
| 264 | AKUS | Akouos Inc. | 13.29 | 0.14 (1.06%) | 490.88M | NR |
| 265 | KIN | Kindred Biosciences, Inc. | 9.25 | 0.01 (0.11%) | 420.52M | NR |
| 266 | ARGX | arGEN-X SE ADR | 551.22 | -26.67 (-4.62%) | 33.66B | D |
| 267 | PSNL | Personalis, Inc. | 6.45 | 0.44 (7.32%) | 569.70M | D |
| 268 | URGN | UroGen Pharma Ltd. - Ordinary Shares | 14.34 | 2.31 (19.20%) | 661.17M | D |
| 269 | MTNB | Matinas Biopharma Holdings, Inc. | 0.93 | 0.09 (10.88%) | 4.74M | D |
| 270 | PRDS | Pardes Biosciences, Inc. | 2.16 | 0.00 (0.00%) | 133.95M | NR |
| 271 | NRBO | NeuroBo Pharmaceuticals Inc. | 2.36 | 0.01 (0.43%) | 20.33M | D |
| 272 | BLTE | Belite Bio, Inc | 59.99 | 0.44 (0.74%) | 1.91B | D |
| 273 | TSHA | Taysha Gene Therapies Inc. | 2.56 | 0.02 (0.79%) | 549.53M | D |
| 274 | XXII | 22nd Century Group, Inc. | 0.62 | -0.03 (-4.04%) | 1.46M | D |
| 275 | SBTX | Silverback Therapeutics Inc. | 5.87 | 0.06 (1.03%) | 211.66M | NR |
| 276 | OMER | Omeros Corporation | 3.37 | -0.03 (-0.88%) | 197.46M | D |
| 277 | ENTA | Enanta Pharmaceuticals, Inc. | 7.28 | -0.22 (-2.93%) | 155.62M | D |
| 278 | DARE | Daré Bioscience, Inc. | 2.97 | -0.06 (-1.98%) | 26.28M | D |
| 279 | ONCS | OncoSec Medical Incorporated | 0.28 | 0.07 (31.87%) | 1.26M | NR |
| 280 | IPA | ImmunoPrecise Antibodies Ltd. | 0.85 | 0.15 (21.17%) | 38.90M | D |
| 281 | VYNE | VYNE Therapeutics Inc. | 0.91 | 0.01 (1.29%) | 13.86M | D |
| 282 | NERV | Minerva Neurosciences, Inc | 1.78 | -0.02 (-1.11%) | 12.45M | D |
| 283 | HOWL | Werewolf Therapeutics, Inc. | 1.30 | 0.08 (6.56%) | 58.34M | D |
| 284 | OVID | Ovid Therapeutics Inc. | 0.29 | 0.01 (3.71%) | 20.66M | D |
| 285 | ADXS | Advaxis, Inc. | 0.12 | 0.09 (280.70%) | 5.13M | NR |
| 286 | ADAG | Adagene Inc. | 1.93 | -0.02 (-1.03%) | 90.92M | D |
| 287 | ALEC | Alector, Inc. | 1.51 | -0.03 (-1.95%) | 150.99M | D |
| 288 | MMEDF | Mind Medicine (MindMed) Inc. | 4.69 | 1.17 (33.24%) | N/A | NR |
| 289 | RLYB | Rallybio Corp | 0.35 | 0.03 (8.64%) | 14.65M | D |
| 290 | RCUS | Arcus Biosciences, Inc. | 9.09 | -0.15 (-1.62%) | 962.49M | D |
| 291 | INM | InMed Pharmaceuticals Inc. | 2.37 | -0.16 (-6.32%) | 2.86M | D |
| 292 | EIGR | Eiger BioPharmaceuticals, Inc. | 1.73 | -0.18 (-9.21%) | 2.55M | NR |
| 293 | DNA | Ginkgo Bioworks Holdings, Inc. | 9.17 | 0.23 (2.57%) | 536.74M | D |
| 294 | NHWK | NightHawk Biosciences, Inc., | 0.41 | 0.03 (8.96%) | 10.78M | NR |
| 295 | GALT | Galectin Therapeutics Inc. | 1.49 | 0.12 (8.76%) | 94.31M | D |
| 296 | VCNX | Vaccinex, Inc. | 0.71 | -0.11 (-13.41%) | 1.85M | D |
| 297 | APRE | APREA THERAPEUTICS, INC. | 1.77 | -0.07 (-3.81%) | 9.79M | NR |
| 298 | NMTR | 9 Meters Biopharma, Inc. | 0.07 | -0.05 (-42.97%) | 1.04M | NR |
| 299 | ELDN | Eledon Pharmaceuticals, Inc. | 2.80 | -0.07 (-2.44%) | 167.67M | D |
| 300 | GANX | Gain Therapeutics, Inc. | 1.74 | 0.01 (0.58%) | 52.11M | D |
| 301 | EVAX | Evaxion Biotech A/S | 2.40 | -0.37 (-13.36%) | 3.37M | D |
| 302 | BPTS | Biophytis SA | 8.22 | -1.48 (-15.28%) | 2.89M | NR |
| 303 | AGIO | Agios Pharmaceuticals, Inc. | 35.75 | 1.45 (4.23%) | 2.07B | D |
| 304 | RAIN | Rain Therapeutics Inc. | 3.27 | -0.21 (-5.95%) | 24.81M | NR |
| 305 | VIRI | Virios Therapeutics, Inc. | 0.16 | 0.02 (12.40%) | 2.98M | NR |
| 306 | INZY | Inozyme Pharma Inc. | 3.97 | -0.02 (-0.50%) | 256.31M | D |
| 307 | CNCE | Concert Pharmaceuticals, Inc. | 8.37 | 0.01 (0.12%) | 401.24M | NR |
| 308 | VLON | Vallon Pharmaceuticals, Inc. | 0.40 | -0.06 (-13.04%) | 5.39M | NR |
| 309 | NAUT | Nautilus Biotechnology, Inc. | 0.72 | 0.02 (2.71%) | 90.83M | D |
| 310 | UNCY | Unicycive Therapeutics, Inc., | 0.75 | 0.07 (10.70%) | 90.99M | D |
| 311 | GRNA | GreenLight Biosciences Holdings, | 0.30 | -0.00 (-0.03%) | 45.43M | NR |
| 312 | LGND | Ligand Pharmaceuticals Incorporated | 115.01 | 2.51 (2.23%) | 2.22B | D |
| 313 | CFRX | ContraFect Corporation | 0.05 | -0.02 (-27.95%) | 535.25K | NR |
| 314 | CYCC | Cyclacel Pharmaceuticals, Inc. | 0.34 | -0.07 (-17.25%) | 7.66M | D |
| 315 | XBIO | Xenetic Biosciences, Inc. | 2.80 | -0.21 (-7.07%) | 4.32M | NR |
| 316 | LBPS | 4D pharma plc | 1.65 | 0.04 (2.48%) | 27.11M | NR |
| 317 | AURA | Aura Biosciences, Inc. | 6.40 | -0.02 (-0.31%) | 321.72M | D |
| 318 | CVM | Cel-Sci Corporation | 2.50 | 0.25 (11.11%) | 7.58M | D |
| 319 | DBVT | DBV Technologies S.A. | 9.55 | 0.45 (4.95%) | 261.57M | D |
| 320 | ATNF | 180 Life Sciences Corp. | 0.96 | -0.03 (-2.54%) | 5.47M | D |
| 321 | COGT | Cogent Biosciences, Inc. | 7.49 | 0.41 (5.79%) | 852.78M | D |
| 322 | ONTX | Onconova Therapeutics, Inc. | 1.00 | -0.00 (-0.47%) | 20.90M | NR |
| 323 | TNYA | Tenaya Therapeutics, Inc. | 0.62 | 0.03 (5.21%) | 101.23M | D |
| 324 | PRTC | PureTech Health PLC | 19.25 | -0.36 (-1.84%) | 462.37M | NR |
| 325 | ANCN | Anchiano Therapeutics Ltd. - American Depositary Share | 4.71 | 0.24 (5.37%) | 34.95M | NR |
| 326 | BCLI | Brainstorm Cell Therapeutics Inc. | 1.24 | 0.14 (12.73%) | 9.84M | D |
| 327 | NGM | NGM Biopharmaceuticals, Inc. | 1.54 | -0.02 (-1.28%) | 128.53M | D |
| 328 | LABP | Landos Biopharma, Inc. | 22.93 | 0.13 (0.58%) | 71.68M | D |
| 329 | ANPC | AnPac Bio-Medical Science Co., Ltd. | 4.37 | -0.25 (-5.41%) | 4.23M | NR |
| 330 | VTGN | VistaGen Therapeutics, Inc. | 2.36 | 0.15 (6.79%) | 68.11M | D |
| 331 | ORPH | Orphazyme A/S ADR | 0.87 | -0.02 (-2.25%) | 30.72M | NR |
| 332 | BLI | Berkeley Lights Inc. | 1.20 | -0.08 (-5.88%) | 86.61M | NR |
| 333 | CANF | Can-Fite Biopharma Ltd Sponsored ADR (Israel) | 1.14 | 0.07 (6.54%) | 4.04M | D |
| 334 | AVXL | Anavex Life Sciences Corp. | 8.61 | 0.58 (7.22%) | 735.05M | D |
| 335 | HTBX | Heat Biologics, Inc. | 2.38 | 0.01 (0.42%) | 61.05M | NR |
| 336 | IKT | Inhibikase Therapeutics Inc. | 1.94 | 0.08 (4.30%) | 144.22M | D |
| 337 | CBAY | CymaBay Therapeutics Inc. | 32.48 | 0.01 (0.03%) | 3.73B | NR |
| 338 | MBIO | Mustang Bio, Inc. | 1.11 | -0.06 (-5.13%) | 4.86M | D |
| 339 | COCP | Cocrystal Pharma, Inc. | 1.46 | -0.08 (-5.19%) | 14.85M | NR |
| 340 | PLRX | Pliant Therapeutics Inc. | 1.36 | -0.02 (-1.45%) | 83.48M | D |
| 341 | BIAF | bioAffinity Technologies Inc. | 0.26 | -0.01 (-4.79%) | 7.46M | D |
| 342 | CRVS | Corvus Pharmaceuticals, Inc. | 4.26 | 0.07 (1.67%) | 290.40M | D |
| 343 | BPTH | Bio-Path Holdings, Inc. | 0.19 | 0.00 (1.28%) | 1.58M | D |
| 344 | TYRA | Tyra Biosciences, Inc. | 10.22 | -0.21 (-2.01%) | 542.58M | D |
| 345 | CARA | Cara Therapeutics, Inc. | 5.32 | -0.23 (-4.14%) | 24.33M | D |
| 346 | AMTI | Applied Molecular Transport Inc. | 0.26 | -0.04 (-14.30%) | 10.87M | NR |
| 347 | VBIV | VBI Vaccines, Inc. - Ordinary Shares | 0.07 | -0.07 (-50.87%) | 1.87M | NR |
| 348 | CMRX | Chimerix, Inc. | 8.54 | -0.01 (-0.12%) | 801.09M | D |
| 349 | RAPT | RAPT THERAPEUTICS, INC. | 1.03 | -0.01 (-0.96%) | 136.26M | D |
| 350 | BCDA | BioCardia, Inc. | 2.30 | 0.12 (5.50%) | 11.91M | D |
| 351 | ADMA | ADMA Biologics Inc | 20.40 | -0.41 (-1.97%) | 4.87B | D |
| 352 | LMNL | Liminal Biosciences Inc. | 8.50 | 0.01 (0.12%) | 26.38M | NR |
| 353 | IDRA | Idera Pharmaceuticals, Inc. | 0.43 | -0.12 (-21.57%) | 26.50M | NR |
| 354 | GOVX | GeoVax Labs, Inc. | 1.32 | 0.29 (28.16%) | 20.06M | D |
| 355 | IMNM | Immunome Inc. | 9.54 | 0.34 (3.70%) | 830.09M | D |
| 356 | XLRN | Acceleron Pharma Inc. | 178.75 | -0.93 (-0.52%) | 10.93B | NR |
| 357 | ALGS | Aligos Therapeutics Inc. | 8.05 | 0.34 (4.41%) | 49.22M | D |
| 358 | ENTX | Entera Bio Ltd | 2.00 | 0.14 (7.53%) | 90.90M | D |
| 359 | SRRA | Sierra Oncology, Inc. | 54.99 | 0.02 (0.04%) | 1.34B | NR |
| 360 | PULM | Pulmatrix, Inc. | 8.70 | 0.89 (11.40%) | 31.76M | D |
| 361 | GNPX | Genprex, Inc. | 0.31 | 0.02 (5.45%) | 8.56M | D |
| 362 | NDRA | ENDRA Life Sciences Inc. | 3.39 | -0.06 (-1.74%) | 2.50M | D |
| 363 | PAND | Pandion Therapeutics Inc. | 60.05 | 0.13 (0.22%) | 1.77B | NR |
| 364 | ICVX | Icosavax, Inc. | 15.31 | -0.14 (-0.91%) | 766.88M | NR |
| 365 | BHVN | Biohaven Pharmaceutical Holding Company Ltd. Common Shares | 15.18 | -0.28 (-1.81%) | 1.55B | D |
| 366 | MRNS | Marinus Pharmaceuticals, Inc. | 0.55 | -0.00 (-0.16%) | 30.32M | D |
| 367 | CLBS | Caladrius Biosciences, Inc. | 0.43 | -0.08 (-16.44%) | 25.83M | NR |
| 368 | MBRX | Moleculin Biotech, Inc. | 0.69 | 0.04 (6.73%) | 9.68M | D |
| 369 | ACXP | Acurx Pharmaceuticals, Inc. | 0.31 | 0.00 (0.69%) | 7.21M | D |
| 370 | ORMP | Oramed Pharmaceuticals Inc. | 2.16 | 0.04 (1.89%) | 88.24M | D |
| 371 | PHVS | Pharvaris N.V. | 16.96 | 0.26 (1.56%) | 886.84M | D |
| 372 | FMTX | Forma Therapeutics Holdings Inc. | 20.01 | 0.03 (0.15%) | 957.54M | NR |
| 373 | PHIO | Phio Pharmaceuticals Corp | 2.48 | 0.21 (9.25%) | 11.90M | D |
| 374 | POAI | Predictive Oncology Inc. | 0.96 | -0.00 (-0.05%) | 8.57M | D |
| 375 | SRRK | Scholar Rock Holding Corporation | 32.13 | -0.32 (-0.99%) | 3.05B | D |
| 376 | AMAM | Ambrx Biopharma Inc. | 28.00 | 0.02 (0.07%) | 1.77B | NR |
| 377 | XNCR | Xencor, Inc. | 9.05 | -0.14 (-1.52%) | 644.10M | D |
| 378 | AGTC | Applied Genetic Technologies Corporation | 0.39 | 0.00 (1.23%) | 26.62M | NR |
| 379 | KDNY | Chinook Therapeutics, Inc. | 40.39 | 0.09 (0.22%) | 2.90B | NR |
| 380 | KTRA | Kintara Therapeutics, Inc. | 0.22 | -0.01 (-6.31%) | 11.91M | NR |
| 381 | MNPR | MONOPAR THERAPEUTICS | 34.22 | 0.70 (2.09%) | 209.26M | D |
| 382 | CMPX | Compass Therapeutics Inc. | 2.37 | -0.04 (-1.66%) | 327.73M | D |
| 383 | ABOS | Acumen Pharmaceuticals, Inc. | 1.14 | 0.07 (6.54%) | 69.05M | D |
| 384 | CBIO | Catalyst Biosciences, Inc. | 15.80 | -3.52 (-18.25%) | 600.05M | NR |
| 385 | VCEL | Vericel Corporation | 41.59 | -1.08 (-2.53%) | 2.09B | D |
| 386 | JAGX | Jaguar Health, Inc. | 3.45 | -0.04 (-1.15%) | 3.51M | D |
| 387 | BLU | BELLUS Health Inc. | 14.74 | 0.00 (0.00%) | 1.87B | NR |
| 388 | BIVI | BioVie Inc. | 1.09 | -0.05 (-4.39%) | 20.24M | D |
| 389 | OTLK | Outlook Therapeutics, Inc. | 1.77 | -0.05 (-2.75%) | 59.42M | D |
| 390 | MREO | Mereo BioPharma Group plc (Mereo) | 2.76 | 0.00 (0.00%) | 438.84M | D |
| 391 | EVLO | Evelo Biosciences, Inc. | 0.00 | 0.00 (0.00%) | 9.49K | NR |
| 392 | IMPL | IMPEL NEUROPHARMA INC | 0.04 | -0.02 (-27.27%) | 956.00K | NR |
| 393 | IMV | IMV Inc. | 0.82 | -0.02 (-2.55%) | 9.63M | NR |
| 394 | ENVB | Enveric Biosciences Inc. | 1.27 | 0.06 (4.96%) | 3.14M | D |
| 395 | GNCA | Genocea Biosciences, Inc. | 0.00 | 0.00 (0.00%) | 5.87K | NR |
| 396 | GLPG | Galapagos NV | 28.80 | 0.04 (0.14%) | 1.90B | D |
| 397 | FREQ | FREQUENCY THERAPEUTICS, INC. | 0.30 | 0.02 (5.94%) | 10.94M | NR |
| 398 | SYN | Synthetic Biologics, Inc. | 1.02 | 0.01 (0.99%) | 16.16M | NR |
| 399 | TCBP | TC BioPharm (Holdings) PLC ADR | 0.50 | -1.04 (-67.53%) | 205.00K | D |
| 400 | BLRX | BioLineRx Ltd. | 4.67 | -0.02 (-0.43%) | 15.55M | D |
| 401 | DRTS | Alpha Tau Medical Ltd., | 3.00 | -0.03 (-1.06%) | 211.14M | D |
| 402 | DTIL | Precision BioSciences, Inc. | 5.19 | 0.29 (5.92%) | 57.55M | D |
| 403 | RNAZ | TransCode Therapeutics, Inc., | 7.30 | 0.33 (4.73%) | 6.08M | D |
| 404 | ABIO | ARCA biopharma, Inc. | 2.40 | -0.10 (-4.00%) | 34.82M | D |
| 405 | CATB | Catabasis Pharmaceuticals, Inc. | 8.54 | -0.64 (-6.97%) | 33.34M | NR |
| 406 | LXRX | Lexicon Pharmaceuticals, Inc. | 0.67 | -0.00 (-0.22%) | 242.20M | D |
| 407 | GLYC | GlycoMimetics, Inc. | 0.16 | -0.01 (-5.42%) | 10.13M | D |
| 408 | ARDX | Ardelyx, Inc. | 3.66 | 0.06 (1.67%) | 875.67M | D |
| 409 | CNTX | Context Therapeutics Inc. | 0.61 | -0.02 (-3.16%) | 54.67M | D |
| 410 | TTNP | Titan Pharmaceuticals, Inc. | 4.24 | -0.21 (-4.72%) | 3.88M | NR |
| 411 | IMGO | Imago BioSciences, Inc. | 36.01 | 0.01 (0.03%) | 1.22B | NR |
| 412 | AIKI | AIkido Pharma Inc. | 3.56 | 0.01 (0.28%) | 19.53M | NR |
| 413 | BCAB | BioAtla, Inc. | 0.40 | -0.01 (-1.36%) | 23.37M | D |
| 414 | FPRX | Five Prime Therapeutics, Inc. | 38.00 | 0.01 (0.03%) | 1.77B | NR |
| 415 | IMTX | Immatics N.V. | 6.10 | -0.02 (-0.33%) | 741.46M | D |
| 416 | DRMA | Dermata Therapeutics, Inc. | 0.70 | -0.01 (-1.73%) | 4.46M | D |
| 417 | THRD | Third Harmonic Bio Inc. | 5.41 | -0.02 (-0.37%) | 244.14M | D |
| 418 | ALZN | Alzamend Neuro, Inc. | 3.09 | -0.15 (-4.63%) | 2.48M | D |
| 419 | ATOS | Atossa Genetics Inc. | 0.85 | 0.02 (2.48%) | 109.94M | D |
| 420 | PALI | Palisade Bio Inc. | 0.61 | -0.03 (-4.23%) | 2.94M | D |
| 421 | NCNA | NuCana plc - American Depositary Share | 0.13 | 0.02 (14.19%) | 797.30K | D |
| 422 | FWP | Forward Pharma A/S | 1.95 | 0.14 (7.73%) | 13.83M | NR |
| 423 | RCKT | Rocket Pharmaceuticals, Inc. | 2.88 | -0.05 (-1.71%) | 307.54M | D |
| 424 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 0.76 | 0.04 (5.05%) | 35.66M | D |
| 425 | AYLA | Ayala Pharmaceuticals Inc. | 0.50 | 0.03 (5.84%) | 7.46M | NR |
| 426 | XFOR | X4 Pharmaceuticals, Inc. | 2.73 | -0.09 (-3.19%) | 15.80M | D |
| 427 | RVMD | Revolution Medicines Inc. | 39.77 | -0.82 (-2.02%) | 7.41B | D |
| 428 | KZIA | Kazia Therapeutics Limited | 9.05 | -0.25 (-2.69%) | 9.11M | D |
| 429 | OYST | OYSTER POINT PHARMA, INC. | 11.17 | 0.02 (0.18%) | 299.85M | NR |
| 430 | VAXX | Vaxxinity, Inc. | 0.01 | 0.01 (9,900.00%) | 1.27M | D |
| 431 | CGTX | Cognition Therapeutics | 0.32 | 0.02 (7.95%) | 19.96M | D |
| 432 | AEZS | Aeterna Zentaris Inc. | 5.72 | 0.32 (5.93%) | 10.26M | NR |
| 433 | ONCY | Oncolytics Biotech Inc. | 0.64 | 0.03 (5.35%) | 55.45M | D |
| 434 | PSTV | PLUS THERAPEUTICS, Inc. | 0.31 | -0.01 (-1.62%) | 5.25M | D |
| 435 | ANNX | Annexon Inc. | 2.44 | -0.05 (-2.01%) | 267.70M | D |
| 436 | INSM | Insmed, Inc. | 101.59 | 2.86 (2.90%) | 18.50B | D |
| 437 | TARA | Protara Therapeutics, Inc. | 3.17 | 0.03 (0.96%) | 122.30M | D |
| 438 | UBX | Unity Biotechnology, Inc. | 0.81 | 0.01 (1.64%) | 13.96M | D |
| 439 | ALDX | Aldeyra Therapeutics, Inc. | 3.02 | 0.24 (8.63%) | 180.89M | D |
| 440 | KDMN | Kadmon Holdings, Inc. | 9.50 | 0.02 (0.21%) | 1.70B | NR |
| 441 | EQRX | EQRx, Inc. | 2.34 | -0.05 (-2.09%) | 1.14B | NR |
| 442 | KOD | Kodiak Sciences Inc | 3.74 | -0.14 (-3.61%) | 197.34M | D |
| 443 | NUVB | Nuvation Bio Inc. | 1.86 | 0.13 (7.51%) | 632.89M | D |
| 444 | VSTM | Verastem, Inc. | 5.64 | 0.04 (0.71%) | 309.91M | D |
| 445 | XENE | Xenon Pharmaceuticals Inc. | 32.02 | -0.74 (-2.26%) | 2.46B | D |
| 446 | MTP | Midatech Pharma PLC | 0.29 | -0.06 (-18.52%) | 6.18M | NR |
| 447 | CLXT | Calyxt, Inc. | 6.30 | 0.33 (5.53%) | 31.34M | NR |
| 448 | EFTR | eFFECTOR Therapeutics, Inc. | 0.00 | 0.00 (50.00%) | 1.41K | D |
| 449 | TCRR | TCR2 Therapeutics Inc. | 1.48 | -0.09 (-5.73%) | 58.11M | NR |
| 450 | CHRS | Coherus BioSciences, Inc. | 0.79 | 0.02 (3.07%) | 91.02M | D |
| 451 | PEPG | PepGen Inc., | 1.49 | 0.06 (4.20%) | 48.75M | D |
| 452 | OMGA | Omega Therapeutics, Inc. | 0.14 | -0.02 (-10.82%) | 7.90M | D |
| 453 | EDSA | Edesa Biotech, Inc. | 2.06 | 0.14 (7.29%) | 14.47M | NR |
| 454 | CBLI | Cleveland BioLabs, Inc. | 3.17 | -0.25 (-7.31%) | 49.07M | NR |
| 455 | MRNA | Moderna Inc. | 26.00 | -0.67 (-2.51%) | 10.06B | D |
| 456 | AGE | AgeX Therapeutics, Inc. | 11.10 | -1.50 (-11.90%) | 11.97M | NR |
| 457 | SLDB | Solid Biosciences Inc. | 5.02 | 0.51 (11.31%) | 389.13M | D |
| 458 | NWBO | Northwest Bioth Cmn | 0.27 | -0.01 (-3.78%) | 388.47M | D |
| 459 | GRTS | Gritstone Oncology, Inc. | 0.03 | -0.02 (-31.78%) | 3.50M | D |
| 460 | TRVN | Trevena, Inc. | 1.14 | 0.12 (11.76%) | 1.09M | D |
| 461 | VTYX | Ventyx Biosciences, Inc. | 2.54 | -0.02 (-0.78%) | 180.75M | D |
| 462 | SLS | SELLAS Life Sciences Group, Inc. | 1.61 | -0.05 (-3.01%) | 160.64M | D |
| 463 | KYMR | Kymera Therapeutics Inc. | 46.84 | -0.12 (-0.26%) | 3.05B | D |
| 464 | AGLE | Aeglea BioTherapeutics, Inc. | 12.01 | 0.97 (8.79%) | 48.63M | NR |
| 465 | EVFM | Evofem Biosciences, Inc. | 0.01 | -0.00 (-7.00%) | 1.10M | NR |
| 466 | IMUX | Immunic, Inc. | 0.82 | 0.02 (1.94%) | 78.62M | D |
| 467 | JANX | Janux Therapeutics, Inc. | 23.61 | -1.29 (-5.18%) | 1.40B | D |
| 468 | DSGN | Design Therapeutics, Inc. | 3.87 | 0.03 (0.78%) | 219.70M | D |
| 469 | AVTE | Aerovate Therapeutics, Inc. | 2.68 | 0.00 (0.00%) | 77.68M | D |
| 470 | GLMD | Galmed Pharmaceuticals Ltd. | 1.73 | 0.13 (7.81%) | 2.85M | D |
| 471 | EWTX | Edgewise Therapeutics, Inc. | 14.68 | -0.61 (-3.99%) | 1.54B | D |
| 472 | CWBR | CohBar, Inc. | 0.41 | 0.00 (0.00%) | 1.19M | NR |
| 473 | NNVC | NanoViricides, Inc. NEW | 1.45 | -0.06 (-3.97%) | 23.30M | D |
| 474 | ELEV | Elevation Oncology, Inc. | 0.39 | 0.00 (0.97%) | 22.82M | D |
| 475 | BNOX | Bionomics Limited, | 0.25 | 0.01 (4.20%) | 4.47M | D |
| 476 | INKT | MiNK Therapeutics, Inc. | 7.57 | 0.32 (4.45%) | 30.17M | NR |
| 477 | LBPH | Longboard Pharmaceuticals, Inc., | 59.98 | 0.02 (0.03%) | 2.34B | D |
| 478 | TMBR | Timber Pharmaceuticals, Inc. | 0.35 | 0.01 (3.09%) | 1.21M | NR |
| 479 | VIE | VIELA BIO, INC. | 53.01 | 0.00 (0.00%) | 2.91B | NR |
| 480 | BLCM | Bellicum Pharmaceuticals, Inc. | 0.07 | -0.01 (-6.62%) | 726.83K | NR |
| 481 | SWTX | SPRINGWORKS THERAPEUTICS, INC. | 46.87 | 0.09 (0.19%) | 3.53B | D |
| 482 | NUVL | Nuvalent, Inc. | 76.32 | -1.92 (-2.45%) | 5.48B | D |
| 483 | MORF | Morphic Holding, Inc. | 56.99 | 0.02 (0.04%) | 2.85B | D |
| 484 | PLXP | PLx Pharma, Inc. | 0.02 | 0.00 (0.00%) | 603.16K | NR |
| 485 | ONCR | Oncorus Inc. | 0.13 | -0.00 (-3.08%) | 3.29M | NR |
| 486 | CGEM | Cullinan Oncology Inc. | 8.74 | 0.13 (1.51%) | 515.79M | D |
| 487 | PRPO | Precipio, Inc. | 10.89 | 0.03 (0.32%) | 16.47M | NR |
| 488 | CLGN | CollPlant Biotechnologies Ltd. | 1.65 | 0.23 (16.20%) | 18.90M | NR |
| 489 | CERE | Ceres Inc | 44.96 | 0.33 (0.74%) | 8.19B | NR |
| 490 | HEPA | Hepion Pharmaceuticals, Inc. | 0.08 | 0.01 (10.27%) | 844.66K | D |
| 491 | AMPE | Ampio Pharmaceuticals, Inc. | 0.12 | 0.11 (4,200.00%) | 131.77K | NR |
| 492 | ALRN | Aileron Therapeutics, Inc. | 2.11 | 0.18 (9.33%) | 45.72M | D |
| 493 | NKTX | Nkarta Inc. | 1.89 | 0.03 (1.61%) | 134.11M | D |
| 494 | PDSB | PDS Biotechnology Corporation | 1.78 | 0.03 (1.71%) | 81.36M | D |
| 495 | IMMP | Immutep Limited | 1.71 | -0.03 (-1.72%) | 249.73M | D |
| 496 | CRTX | Cortexyme, Inc. | 1.95 | 0.05 (2.63%) | 58.79M | NR |
| 497 | EARS | Auris Medical Holding Ltd. | 3.05 | -0.05 (-1.77%) | 34.82M | NR |
| 498 | ZIOP | ZIOPHARM Oncology Inc | 0.87 | -0.01 (-0.88%) | 187.12M | NR |
| 499 | ACHV | Achieve Life Sciences, Inc. | 3.10 | -0.15 (-4.62%) | 107.52M | D |
| 500 | COYA | Coya Therapeutics Inc. | 5.45 | -0.18 (-3.20%) | 91.15M | D |
| 501 | TLSA | Tiziana Life Sciences plc - American Depository Share | 1.56 | 0.01 (0.65%) | 182.28M | D |
| 502 | ADGI | Adagio Therapeutics, Inc. | 4.64 | 0.04 (0.87%) | 504.98M | NR |
| 503 | ARTL | Artelo Biosciences, Inc. | 6.40 | -0.80 (-11.05%) | 3.50M | NR |
| 504 | GLTO | Galecto Inc. | 3.32 | -0.03 (-1.04%) | 4.39M | D |
| 505 | CERC | Cerecor Inc. | 2.93 | -0.05 (-1.68%) | 281.31M | NR |
| 506 | ALPN | Alpine Immune Sciences, Inc. | 64.97 | 0.01 (0.02%) | 4.46B | D |
| 507 | PYXS | Pyxis Oncology, Inc. | 1.21 | 0.01 (0.83%) | 74.96M | D |
| 508 | ORIC | Oric Pharmaceuticals Inc. | 9.41 | -0.22 (-2.28%) | 801.96M | D |
| 509 | TNXP | Tonix Pharmaceuticals Holding Corp. | 36.97 | 4.99 (15.60%) | 270.81M | D |
| 510 | IMRX | Immuneering Corp | 2.37 | 0.47 (24.74%) | 85.29M | D |
| 511 | ENOB | Enochian Biosciences, Inc. | 0.70 | 0.00 (0.00%) | 40.80M | NR |
| 512 | PPBT | Purple Biotech Ltd | 2.48 | 0.03 (1.22%) | 3.30M | D |
| 513 | RGLS | Regulus Therapeutics Inc. | 8.22 | 0.11 (1.36%) | 569.10M | D |
| 514 | TIL | Instil Bio, Inc. | 32.97 | -1.26 (-3.68%) | 216.25M | D |
| 515 | PTN | Palatin Technologies, Inc. | 0.09 | -0.08 (-44.65%) | 2.45M | D |
| 516 | CVKD | Cadrenal Therapeutics Inc. | 13.70 | -0.16 (-1.15%) | 26.95M | D |
| 517 | AIM | AIM ImmunoTech Inc. | 0.09 | -0.02 (-19.37%) | 6.86M | NR |
| 518 | ROIV | Roivant Sciences Ltd. | 11.08 | -0.24 (-2.12%) | 7.53B | D |
| 519 | XBIT | XBiotech Inc. | 2.74 | 0.10 (3.79%) | 83.54M | D |
| 520 | NAVB | Navidea Biopharmaceuticals, Inc. | 0.00 | 0.00 (0.00%) | 70.06K | NR |
| 521 | PRQR | ProQR Therapeutics N.V. - Ordinary Shares | 1.90 | 0.02 (1.06%) | 199.90M | D |
| 522 | FBRX | Forte Biosciences, Inc. | 13.60 | 1.52 (12.54%) | 89.53M | D |
| 523 | AUTL | Autolus Therapeutics plc - American Depositary Share | 2.05 | -0.07 (-3.30%) | 545.59M | D |
| 524 | SNCA | Seneca Biopharma, Inc. | 1.66 | -0.02 (-1.19%) | 28.71M | NR |
| 525 | OKYO | OKYO Pharma Limited, | 2.56 | -0.45 (-14.95%) | 86.62M | D |
| 526 | PHAT | PHATHOM PHARMACEUTICALS, INC. | 10.64 | 0.00 (0.00%) | 742.82M | D |
| 527 | ATNM | Actinium Pharmaceuticals, Inc. (Delaware) | 1.53 | 0.04 (2.68%) | 47.73M | D |
| 528 | BLUE | bluebird bio, Inc. | 4.97 | 0.23 (4.85%) | 48.67M | D |
| 529 | NBTX | Nanobiotix S.A. ADR | 4.99 | -0.35 (-6.63%) | 235.19M | NR |
| 530 | QURE | uniQure N.V. - Ordinary Shares | 15.11 | -0.23 (-1.50%) | 827.67M | D |
| 531 | MRUS | Merus N.V. | 53.30 | -1.31 (-2.40%) | 3.69B | D |
| 532 | PRVB | Provention Bio, Inc. | 24.98 | 0.75 (3.10%) | 2.37B | NR |
| 533 | SIOX | Sio Gene Therapies, Inc. | 0.48 | 0.01 (1.70%) | 34.87M | NR |
| 534 | INO | Inovio Pharmaceuticals Inc. | 2.00 | 0.00 (0.00%) | 73.35M | D |
| 535 | LCTX | Lineage Cell Therapeutics, Inc. | 0.86 | 0.05 (6.70%) | 197.48M | D |
| 536 | AFMD | Affimed N.V. | 0.18 | -0.10 (-34.95%) | 2.92M | D |
| 537 | APDN | Applied DNA Sciences Inc | 5.12 | 0.44 (9.52%) | 2.23M | D |
| 538 | RLMD | Relmada Therapeutics, Inc. | 0.71 | 0.01 (1.13%) | 23.50M | D |
| 539 | SMFR | Sema4 Holdings Corp. | 0.31 | 0.07 (26.78%) | 117.17M | NR |
| 540 | OGEN | Oragenics Inc. | 4.35 | -0.01 (-0.23%) | 3.11M | D |
| 541 | ARPO | Aerpio Pharmaceuticals, Inc. | 2.20 | -0.02 (-0.90%) | 104.85M | NR |
| 542 | MLTX | MoonLake Immunotherapeutics, | 42.90 | -1.31 (-2.96%) | 2.75B | D |
| 543 | MDWD | MediWound Ltd. - Ordinary Shares | 20.49 | 0.07 (0.34%) | 221.46M | D |
| 544 | KLDO | Kaleido Biosciences, Inc. | 0.00 | 0.00 (0.00%) | 4.26K | NR |
| 545 | TPTX | Turning Point Therapeutics, Inc. - Common stock | 76.01 | 0.52 (0.69%) | 3.81B | NR |
| 546 | ABVC | ABVC BioPharma, Inc. | 1.95 | 0.18 (10.17%) | 33.11M | D |
| 547 | VERA | Vera Therapeutics, Inc. | 21.85 | -0.89 (-3.91%) | 1.39B | D |
| 548 | BTTX | Better Therapeutics, Inc. | 0.00 | 0.00 (0.00%) | 4.99K | NR |
| 549 | MRVI | Maravai LifeSciences | 2.16 | 0.03 (1.41%) | 550.07M | D |
| 550 | CLRB | Cellectar Biosciences, Inc. | 0.38 | -0.03 (-7.50%) | 17.61M | D |
| 551 | RNXT | RenovoRx, Inc. | 1.31 | 0.01 (0.77%) | 47.91M | D |
| 552 | QLGN | Qualigen Therapeutics Inc | 3.60 | -0.12 (-3.15%) | 2.65M | D |
| 553 | LXXGF | Lexagene Holdings Inc. | 0.08 | -0.02 (-16.48%) | N/A | NR |
| 554 | ACRV | Acrivon Therapeutics Inc. | 1.22 | 0.02 (1.67%) | 38.25M | D |
| 555 | AKRO | Akero Therapeutics, Inc. | 55.75 | 0.13 (0.23%) | 4.44B | D |
| 556 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 1.17 | 0.02 (1.74%) | 3.70M | D |
| 557 | NURO | NeuroMetrix, Inc. | 4.58 | 0.22 (5.05%) | 9.43M | NR |
| 558 | CDTX | Cidara Therapeutics, Inc. | 22.41 | -0.43 (-1.88%) | 281.18M | D |
| 559 | CELU | Celularity Inc., | 1.76 | 0.01 (0.57%) | 42.15M | D |
| 560 | OLMA | Olema Pharmaceuticals | 4.19 | 0.02 (0.48%) | 286.68M | D |
| 561 | PROG | Progenity Inc. | 0.88 | -0.03 (-3.47%) | 162.92M | NR |
| 562 | IOVA | Iovance Biotherapeutics, Inc. | 2.08 | -0.16 (-7.14%) | 694.58M | D |
| 563 | ADVM | Adverum Biotechnologies, Inc. | 2.47 | 0.01 (0.41%) | 51.60M | D |
| 564 | CYBN | Cybin Inc. | 8.04 | -0.31 (-3.71%) | 184.52M | D |
| 565 | SLNO | Soleno Therapeutics, Inc. | 78.15 | -1.00 (-1.26%) | 3.94B | D |
| 566 | CAPR | Capricor Therapeutics, Inc. | 12.38 | 0.60 (5.09%) | 565.48M | D |
| 567 | CYTK | Cytokinetics, Incorporated | 33.78 | -0.60 (-1.75%) | 4.03B | D |
| 568 | CDXS | Codexis, Inc. | 2.24 | 0.01 (0.45%) | 185.57M | D |
| 569 | AKTX | Akari Therapeutics Plc | 1.09 | -0.10 (-8.40%) | 35.07M | NR |
| 570 | NVIV | InVivo Therapeutics Holdings Corp. | 0.32 | -0.17 (-34.28%) | 995.77K | NR |
| 571 | GMDA | Gamida Cell Ltd. - Ordinary Shares | 0.03 | -0.01 (-18.25%) | 5.04M | NR |
| 572 | KRBP | Kiromic Biopharma Inc. | 0.16 | -0.15 (-48.74%) | 251.52K | NR |
| 573 | VLNCF | The Valens Company Inc. | 1.41 | -0.12 (-7.90%) | N/A | NR |
| 574 | MRTX | Mirati Therapeutics, Inc. | 58.70 | -0.10 (-0.17%) | 4.12B | NR |
| 575 | OCGN | Ocugen Inc. | 1.16 | 0.03 (2.65%) | 338.76M | D |
| 576 | TFFP | TFF PHARMACEUTICALS, INC. | 0.07 | -0.10 (-60.05%) | 288.80K | D |
| 577 | EXAI | Exscientia Holdings Limited | 4.84 | 0.15 (3.20%) | 632.93M | D |
| 578 | VINC | Vincerx Pharma, Inc. | 0.05 | -0.00 (-7.45%) | 266.41K | D |
| 579 | OCUL | Ocular Therapeutix, Inc. | 8.75 | 0.02 (0.23%) | 1.39B | D |
| 580 | INMB | INmune Bio Inc. - Common stock | 8.02 | 0.32 (4.16%) | 184.33M | D |
| 581 | LIFE | aTyr Pharma, Inc. | 1.90 | 0.05 (2.70%) | 131.12M | D |
| 582 | DYAI | Dyadic International, Inc. | 0.93 | -0.01 (-1.06%) | 27.98M | D |
| 583 | CRBU | Caribou Biosciences, Inc. | 1.12 | 0.01 (0.90%) | 104.17M | D |
| 584 | NRIX | Nurix Therapeutics Inc. | 11.91 | -0.02 (-0.17%) | 907.97M | D |
| 585 | ISEE | IVERIC bio, Inc. | 39.95 | 0.15 (0.38%) | 5.50B | NR |
| 586 | TNGX | Tango Therapeutics, Inc. | 4.79 | 0.10 (2.13%) | 519.21M | D |
| 587 | IMVT | Immunovant, Inc. | 15.49 | -0.17 (-1.09%) | 2.65B | D |
| 588 | BEAM | Beam Therapeutics Inc. | 16.62 | -0.44 (-2.58%) | 1.67B | D |
| 589 | AZRX | AzurRx BioPharma, Inc. | 3.45 | 0.07 (2.07%) | 32.17M | NR |
| 590 | NTLA | Intellia Therapeutics, Inc. | 8.96 | 0.65 (7.82%) | 928.10M | D |
| 591 | APTO | Aptose Biosciences, Inc. | 1.71 | -1.44 (-45.71%) | 3.66M | D |
| 592 | AXLA | Axcella Health Inc. | 0.40 | -0.04 (-8.89%) | 1.18M | NR |
| 593 | LIPO | Lipella Pharmaceuticals Inc. | 2.87 | 0.23 (8.71%) | 12.82M | D |
| 594 | CYDY | CytoDyn Inc. | 0.35 | -0.00 (-0.96%) | 437.14M | NR |
| 595 | SAVA | Cassava Sciences, Inc. | 2.05 | 0.00 (0.00%) | 99.03M | D |
| 596 | BCYC | Bicycle Therapeutics plc | 8.04 | -0.33 (-3.94%) | 556.80M | D |
| 597 | CTXR | Citius Pharmaceuticals, Inc. | 0.79 | -0.08 (-9.66%) | 8.40M | D |
| 598 | REVB | Revelation Biosciences, Inc., | 0.80 | 0.01 (1.03%) | 773.32K | D |
| 599 | LGVN | Longeveron Inc. | 1.29 | -0.01 (-0.77%) | 19.26M | D |
| 600 | ADTX | ADiTx Therapeutics Inc. | 1.38 | 0.00 (0.00%) | 2.93M | D |
| 601 | LRMR | Larimar Therapeutics, Inc. | 2.89 | 0.01 (0.35%) | 185.04M | D |
| 602 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 8.74 | -0.09 (-1.02%) | 106.95M | D |
| 603 | ABSI | AbSci Corp | 2.82 | 0.04 (1.44%) | 359.72M | D |
| 604 | PGEN | Precigen, Inc. | 1.54 | 0.02 (1.32%) | 454.58M | D |
| 605 | MNMD | Mind Medicine (MindMed) Inc. | 7.14 | -0.03 (-0.42%) | 539.45M | F |
| 606 | DICE | DICE Therapeutics, Inc. | 47.55 | 0.03 (0.06%) | 2.27B | NR |
| 607 | KTTA | Pasithea Therapeutics Corp. | 0.77 | -0.01 (-1.42%) | 5.77M | F |
| 608 | XCUR | Exicure, Inc. | 8.83 | 0.06 (0.68%) | 55.79M | F |
| 609 | ZSAN | Zosano Pharma Corporation | 0.56 | 0.04 (7.23%) | 2.73M | NR |
| 610 | PRPH | ProPhase Labs, Inc. | 0.33 | 0.00 (0.39%) | 13.82M | F |
| 611 | RANI | Rani Therapeutics Holdings, Inc. | 0.52 | -0.01 (-0.99%) | 29.90M | F |
| 612 | BXRX | Baudax Bio, Inc. | 0.02 | 0.00 (7.39%) | 1.14M | NR |
| 613 | TBIO | Translate Bio, Inc. | 0.05 | -0.20 (-79.91%) | 90.10K | F |
| 614 | FDMT | 4D Molecular Therapeutics Inc. | 4.37 | -0.02 (-0.46%) | 202.44M | F |
| 615 | IBIO | iBio, Inc. | 0.87 | -0.05 (-5.83%) | 14.44M | F |
| 616 | APVO | Aptevo Therapeutics Inc. | 3.66 | -0.73 (-16.63%) | 1.48M | F |
| 617 | CRSP | CRISPR Therapeutics AG | 41.58 | 0.22 (0.53%) | 3.59B | F |
| 618 | JSPR | Jasper Therapeutics, Inc., | 5.63 | 0.05 (0.90%) | 84.57M | F |
| 619 | KRTX | Karuna Therapeutics, Inc. | 329.83 | 0.09 (0.03%) | 12.58B | NR |
| 620 | CMRA | Comera Life Sciences Holdings, Inc. | 0.00 | 0.00 (100.00%) | 6.15K | NR |
| 621 | LPTX | Leap Therapeutics, Inc. | 0.39 | -0.02 (-4.29%) | 16.26M | F |
| 622 | ALT | Altimmune, Inc. | 6.87 | -0.05 (-0.72%) | 557.21M | F |
| 623 | VRPX | Virpax Pharmaceuticals, Inc. | 0.24 | 0.01 (4.27%) | 300.56K | F |
| 624 | HUMA | Humacyte, Inc. | 2.41 | 0.04 (1.69%) | 373.84M | F |
| 625 | CABA | CABALETTA BIO, INC. | 1.94 | -0.06 (-2.76%) | 98.19M | F |
| 626 | DYN | Dyne Therapeutics, Inc. | 13.82 | -0.59 (-4.09%) | 1.57B | F |
| 627 | AKER | Akers Biosciences Inc. | 2.47 | -0.26 (-9.52%) | 41.13M | NR |
| 628 | PRAX | Praxis Precision Medicines Inc. | 43.81 | -0.49 (-1.11%) | 892.37M | F |
| 629 | PRME | Prime Medicine Inc. | 1.50 | 0.04 (2.74%) | 196.94M | F |
| 630 | SANA | Sana Biotechnology, Inc. | 2.52 | -0.07 (-2.70%) | 568.20M | F |
| 631 | TYHT | Shineco, Inc. | 11.09 | -0.45 (-3.90%) | 97.24M | NR |
| 632 | ETNB | 89BIO, INC. | 10.05 | -0.36 (-3.46%) | 1.47B | F |
| 633 | ABCL | AbCellera Biologics Inc. | 3.16 | -0.04 (-1.25%) | 943.02M | F |
| 634 | AGFY | Agrify Corporation | 23.79 | -2.21 (-8.50%) | 46.44M | F |
| 635 | CBUS | Cibus Inc. | 1.58 | 0.10 (6.40%) | 51.60M | F |
| 636 | QSI | Quantum-Si incorporated | 1.77 | 0.11 (6.63%) | 324.79M | F |
| 637 | CRDF | Cardiff Oncology, Inc. | 3.86 | 0.05 (1.31%) | 256.79M | F |
| 638 | BFRG | Bullfrog AI Holdings Inc. | 1.74 | 0.05 (2.96%) | 16.38M | F |
| 639 | RNA | Avidity Biosciences Inc. | 29.80 | -1.57 (-5.00%) | 3.59B | F |
| 640 | CLDX | Celldex Therapeutics Inc. | 20.34 | -0.92 (-4.33%) | 1.35B | F |
| NR | ANACU | Anacor Pharmaceuticals, Inc. | 0.00 | 0.00 (0.00%) | N/A | NR |
| NR | RVVTF | Revive Therapeutics Ltd. | 0.02 | 0.00 (0.00%) | N/A | NR |
| NR | RCOR | Renovacor, Inc., | 3.20 | 0.15 (4.92%) | 55.26M | NR |
| NR | VLNS | Valens Co. Inc. | 0.76 | 0.00 (0.03%) | 61.38M | NR |
| NR | RSCF | Reflect Scientific Inc. | 0.06 | 0.00 (0.00%) | N/A | NR |
| NR | ANTH | Anthera Pharmaceuticals, Inc. | 0.00 | 0.00 (0.00%) | N/A | NR |
| NR | SPHS | Sophiris Bio, Inc. | 0.00 | 0.00 (0.00%) | 3.56K | NR |
| NR | ENZN | Enzon Pharmaceuticals | 0.08 | -0.01 (-6.39%) | 6.09M | NR |
| NR | CYAD | Celyad SA | 0.47 | -0.06 (-11.10%) | 10.62M | NR |
| NR | PHGE | BiomX Inc. | 0.41 | 0.00 (0.00%) | 10.71M | NR |
| NR | AMRH | Enveric Biosciences Inc. | 1.48 | -0.22 (-12.94%) | 11.09M | NR |
| NR | NVUS | Eledon Pharmaceuticals, Inc. | 14.60 | -0.80 (-5.19%) | 20.97M | NR |
| NR | KMPHD | KemPharm, Inc. | 8.25 | -1.06 (-11.39%) | 35.60M | NR |
| NR | ICCC | ImmuCell Corporation | 6.35 | -0.14 (-2.16%) | 57.38M | NR |
| NR | MGEN | Miragen Therapeutics, Inc. | 23.01 | -0.02 (-0.09%) | 89.92M | NR |
| NR | XYNO | Xynomic Pharmaceuticals Holdings, Inc. | 2.22 | 0.06 (2.78%) | 102.73M | NR |
| NR | PDLI | PDL BioPharma, Inc. | 2.47 | -0.23 (-8.52%) | 282.14M | NR |
| NR | HQL | Tekla Life Sciences Investors | 12.83 | -0.02 (-0.16%) | 370.43M | NR |
| NR | OPT | Opthea Ltd. ADR | 3.41 | 0.23 (7.23%) | 524.84M | NR |
| NR | PHAR | Pharming Group NV | 11.32 | 0.57 (5.28%) | 770.11M | NR |
| NR | PRVL | Prevail Therapeutics Inc. - common stock | 23.00 | -0.02 (-0.09%) | 787.66M | NR |
All price changes on this page include dividends and splits.